SMT, PCB Electronics Industry News

Rapid Response Strep A Tests

Oct 16, 2009

BTNX’S Rapid Response® Strep A test is a qualitative lateral flow immunoassay for the detection of group A streptococcus, or group A strep, carbohydrate antigen in a throat swab for professional in-vitro diagnostic.

Toronto, Canada – BTNX Inc. has launched a Rapid Response® advanced FDA cleared & CLIA waived in-vitro diagnostic group A streptococcus, or strep A, test, which is a qualitative lateral flow immunoassay for the detection of strep A carbohydrate antigen in a throat swab.

Strep A is a bacterium that is commonly found in the throat and on the skin. Strep A bacteria might cause no symptoms of disease, but they can also cause infections that range from mild to life-threatening.

Strep A bacteria are spread by direct person-to-person contact. The bacteria are carried in discharges from nose or throat of an infected person and in infected wounds or sores on the skin. The bacteria are usually spread when infected secretions come in the contact with the mouth, nose, or eyes of an uninfected person.

Strep A bacteria usually causes relatively mild illnesses, such as streptococcal sore throat (strep throat) and streptococcal skin infections (impetigo). It can also cause more serious illnesses such as scarlet fever, rheumatic fever, postpartum fever, wound infections, and pneumonia.

Occasionally, a deadly type of strep A bacteria can invade the blood, muscle and fat tissue, or lungs and cause a serious and often life- threatening type infections.

Rapid Response® Strep A test is FDA cleared and CLIA waived, offers 95% accuracy v/s culture (gold Stand) in rare and 1+ colonies and results within 5 minutes, and has no cross reaction with other ?-hemolytic streptococci.

Rapid Response® branded tests are trusted by professionals in laboratories, physicians’ offices, hospitals and clinics worldwide for their diagnostic testing requirements.

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. BTNX Inc. specializes in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests and information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions for laboratories, clinics, hospitals and physicians’ offices.

For more information about the products please visit http://www.BTNX.com , or contact Sales@BTNX.com.

Oct 16, 2009 -

Rapid Response® Point of Care Drugs of Abuse Tests

Oct 16, 2009 -

BTNX Offers Free Blood Glucose Meters

Apr 19, 2018 -

ULT LLC cooperates with GulfTech

Apr 18, 2018 -

MicroCare Presents its Latest Advancements in Cleaning at SMT Hybrid Packaging

Apr 18, 2018 -

SMTA Europe's Harsh Environments Conference Session 6 to Focus on Automotive Electronics

Apr 18, 2018 -

IPC Hand Soldering Competition Winner Crowned at Global Industrie/Midest 2018 in Paris

Apr 18, 2018 -

Koh Young Presenting on 3D Technologies at SMTA Rocky Mountain Chapter Technical Session

Apr 17, 2018 -

International Conference for Electronics Enabling Technologies (ICEET) Program Finalized

Apr 17, 2018 -

Seika Announces Plans for Optimized Drying Units to be Incorporated into all McDry Cabinets

Apr 17, 2018 -

Libra Industries Sponsors SMTA Ohio Valley Membership Appreciation Golf Outing

Apr 17, 2018 -

Preview for AdoptSMT for SMT 2018, Stand A4-458 We keep your production running -

Apr 17, 2018 -

cost saving SMT laser cut stencil

See electronics manufacturing industry news »

Rapid Response Strep A Tests news release has been viewed 872 times

Benchtop Fluid Dispenser

SMT Spare Parts and Feeders